How personalized cancer vaccines could keep tumors from coming back: The same mRNA technology that quickly brought the world a vaccine for COVID-19 is now showing promise as a bespoke therapy for cancer.
Personalized cancer vaccines show promise in preventing melanoma recurrence: As part of a 2020 clinical trial, melanoma patients had their tumors surgically removed and received a personalized mRNA vaccine that targeted their cancer to prevent recurrence, with three-year results from Moderna and Merck showing reductions in the risk of recurrence and life span extension. The drugmakers are conducting additional vaccine trials that address other cancers, which is made possible using Moderna’s “single use personalized RNA+” machine that churns out mRNA encoding up to 34 cancer mutations selected by AI.